We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

170 hedge funds and large institutions have $300M invested in Antares Pharma, Inc. in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 42

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

3% less call options, than puts

Call options by funds: $461K | Put options by funds: $477K

3% less funds holding

Funds holding: 175 → 170 (-5)

16% less capital invested

Capital invested by funds: $356M → $300M (-$56.3M)

Holders
170
Holders Change
-5
Holders Change %
-2.86%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
70
Reduced
42
Closed
19
Calls
$461K
Puts
$477K
Net Calls
-$16K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$2.22M
2
RCMNY
Rubric Capital Management (New York)
New York
+$2.02M
3
TAM
Tocqueville Asset Management
New York
+$1.74M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.41M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.18M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.07M
3
Morgan Stanley
Morgan Stanley
New York
-$2.38M
4
BAS
Brown Advisory Securities
Maryland
-$1.2M
5
Deutsche Bank
Deutsche Bank
Germany
-$955K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
26
State Board of Administration of Florida Retirement System
Florida
$2.29M +$213K +52,768 +9%
TAM
27
Tocqueville Asset Management
New York
$2.21M +$1.74M +430,000 +244%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.17M +$100K +24,787 +4%
PCM
29
Perkins Capital Management
Minnesota
$1.97M -$4.04K -1,000 -0.2%
HVC
30
Healthcare Value Capital
New Jersey
$1.82M – – –
Deutsche Bank
31
Deutsche Bank
Germany
$1.72M -$955K -236,297 -33%
Goldman Sachs
32
Goldman Sachs
New York
$1.55M +$226K +55,818 +15%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.29M +$21.4K +5,300 +2%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$1.27M +$1.41M +349,593 New
Renaissance Technologies
35
Renaissance Technologies
New York
$1.1M +$1.23M +303,128 New
AC
36
Avenir Corporation
Virginia
$1.1M – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$1.07M +$610K +150,979 +105%
Millennium Management
38
Millennium Management
New York
$1.06M -$725K -179,353 -38%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$1.03M +$35.8K +8,859 +3%
Invesco
40
Invesco
Georgia
$1.02M +$125K +31,026 +12%
BGIM
41
Brandywine Global Investment Management
Pennsylvania
$1.02M -$11.6K -2,864 -1%
SCM
42
Stonepine Capital Management
Oregon
$961K +$1.07M +264,100 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$946K -$99.9K -24,719 -9%
GCP
44
GSA Capital Partners
United Kingdom
$934K +$66K +16,319 +7%
AQR Capital Management
45
AQR Capital Management
Connecticut
$911K -$150K -37,112 -13%
Baird Financial Group
46
Baird Financial Group
Wisconsin
$895K +$20.2K +5,000 +2%
First Trust Advisors
47
First Trust Advisors
Illinois
$880K +$977K +241,648 New
RMCM
48
Reynders McVeigh Capital Management
Massachusetts
$854K -$101K -25,000 -10%
OAM
49
Oberweis Asset Management
Illinois
$822K +$102K +25,300 +13%
Squarepoint
50
Squarepoint
New York
$819K +$396K +97,989 +77%
1
2
3 4 5

ATRS Hedge Fund Activity: Q3 2021 in Review

170 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q3 2021, worth a combined $300M — down 16% from $356M a quarter earlier.

Fund positioning in ATRS was balanced in Q3 2021: 19 funds opened new positions, 19 closed out, 70 added to existing stakes and 42 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $2.22M. The largest seller was Fidelity Investments, cutting an estimated $8.18M.

  • 170 institutional investors held Antares Pharma, Inc. (ATRS) as of Q3 2021, down from 175 in Q2 2021.
  • Funds reported $300M of Antares Pharma, Inc. stock for Q3 2021, down 16% quarter-over-quarter.
  • 19 funds opened new Antares Pharma, Inc. positions in Q3 2021 and 19 closed out, a net change of 0 holders.
  • The largest Antares Pharma, Inc. buyer in Q3 2021 was Magnetar Financial, an estimated $2.22M added.
  • The largest Antares Pharma, Inc. seller in Q3 2021 was Fidelity Investments, an estimated $8.18M sold.

Based on aggregated 13F filings for Q3 2021.